High-volume hemofiltration in the intensive care unit: A blood purification therapy

Anesthesiology

Volumn 116, Issue 6, 2012, Pages 1377-1387

  Rimmelé, Thomas ^a   Kellum, John A ^b  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; GLUCOSE; PHOSPHORUS; POTASSIUM; SODIUM;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; APACHE; BIOCOMPATIBILITY; CONCENTRATION (PARAMETERS); CONTINUOUS HEMODIAFILTRATION; CRITICALLY ILL PATIENT; DIFFUSION; DISEASE SEVERITY; ENDOTOXEMIA; FLOW RATE; HEART MUSCLE; HEMODIALYSIS; HEMODYNAMICS; HEMOFILTRATION; HIGH VOLUME HEMOFILTRATION; HUMAN; HYDROPHOBICITY; INTENSIVE CARE UNIT; KIDNEY BLOOD FLOW; MOLECULAR WEIGHT; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREATITIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PURIFICATION; REVIEW; SEPTIC SHOCK; THERAPY EFFECT; ULTRAFILTRATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEMOFILTRATION; HUMANS; INFLAMMATION; INTENSIVE CARE; INTENSIVE CARE UNITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY; TERMINOLOGY AS TOPIC;

EID: 84861635418     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318256f0c0     Document Type: Review

References (88)

1. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W: Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30:2051-8
2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294:813-8
3. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361:1627-38
4. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20
5. Kellum JA, Ronco C: Dialysis: Results of RENAL-what is the optimal CRRT target dose? Nat Rev Nephrol 2010; 6:191-2
6. Overberger P, Pesacreta M, Palevsky PM: VA/NIH Acute Renal Failure Trial Network: Management of renal replacement therapy in acute kidney injury: A survey of practitioner prescribing practices. Clin J Am Soc Nephrol 2007; 2:623-30
7. Palevsky PM: Indications and timing of renal replacement therapy in acute kidney injury. Crit Care Med 2008; 36: S224-8
8. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA: Continuous renal replacement therapy: A worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007; 33:1563-70
9. Ghahramani N, Shadrou S, Hollenbeak C: A systematic review of continuous renal replacement therapy and intermittent haemodialysis in management of patients with acute renal failure. Nephrology 2008; 13:570-8
10. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M, Alberta Kidney Disease Network: Renal replacement therapy in patients with acute renal failure: A systematic review. JAMA 2008; 299:793-805
11. Rabindranath K, Adams J, Macleod AM, Muirhead N: Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007; 3:CD003773
12. Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, Mariano F, Formica M, Marchesi M, René R, Livigni S, Ronco C, DOse REsponse Multicentre International Collaborative Initiative (DO-RE-MI Study Group): Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 2009; 13:R57
13. Cole L, Bellomo R, Silvester W, Reeves JH: A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med 2000; 162:191-6
14. Boussekey N, Chiche A, Faure K, Devos P, Guery B, d'Escrivan T, Georges H, Leroy O: A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008; 34: 1646-53
15. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C, ADQI Workgroup: The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002; 62:1855-63
16. Honore PM, Joannes-Boyau O, Kotulak T: Report of the working party on high volume hemofiltration including definitions and classification. Paper presented at: Proc 2nd Czech Conference on Critical Care Nephrology; 2007; Pardubice, Czech Republic, April 18-19, 2007
17. Honore PM, Joannes-Boyau O, Boer W, Collin V: High-volume hemofiltration in sepsis and SIRS: Current concepts and future prospects. Blood Purif 2009; 28:1-11
18. Brendolan A, D'Intini V, Ricci Z, Bonello M, Ratanarat R, Salvadori G, Bordoni V, De Cal M, Andrikos E, Ronco C: Pulse high volume hemofiltration. Int J Artif Organs 2004; 27:398-403
19. Honore PM, Jamez J, Wauthier M: Very high volume hemofiltration: A comprehensive review. Proceedings from the International Symposium on Critical Care Nephrology (ISCCN). Melbourne, Australia, November 1-3, 2001
20. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26-30
21. Schiffl H, Lang SM, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-10
22. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 2002; 30: 2205-11
23. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM: Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008; 19:1233-8
24. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY: Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70:1312-7
25. Bellomo R, Warrillow SJ, Reade MC: Why we should be wary of single-center trials. Crit Care Med 2009; 37:3114-9
26. Eckmanns T, Bessert J, Behnke M, Gastmeier P, Ruden H: Compliance with antiseptic hand rub use in intensive care units: The Hawthorne effect. Infect Control Hosp Epidemiol 2006; 27:931-4
27. Bellomo R: Do we know the optimal dose for renal replacement therapy in the intensive care unit? Kidney Int 2006; 70:1202-4
28. Jun M, Heerspink HJ, Ninomiya T, Gallagher M, Bellomo R, Myburgh J, Finfer S, Palevsky PM, Kellum JA, Perkovic V, Cass A: Intensities of renal replacement therapy in acute kidney injury: A systematic review and meta-analysis. Clin J Am Soc Nephrol 2010; 5:956-63
29. Van Wert R, Friedrich JO, Scales DC, Wald R, Adhikari NK, University of Toronto Acute Kidney Injury Research Group: High-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis. Crit Care Med 2010; 38:1360-9
30. Honoré PM, Jacobs R, Boer W, Joannes-Boyau O, De Regt J, De Waele E, Van Gorp V, Collin V, Spapen HD: New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury. Blood Purif 2011; 33:44-51
31. Hoste EA, Schurgers M: Epidemiology of acute kidney injury: How big is the problem? Crit Care Med 2008; 36:S146-51
32. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC, GenIMS Investigators: Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007; 167:1655-63
33. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N: Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006; 355:1018-28
34. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA: The sepsis seesaw: Tilting toward immunosuppression. Nat Med 2009; 15:496-7
35. Adib-Conquy M, Cavaillon JM: Compensatory anti-inflammatory response syndrome. Thromb Haemost 2009; 101:36-47
36. Turnbull IR, Clark AT, Stromberg PE, Dixon DJ, Woolsey CA, Davis CG, Hotchkiss RS, Buchman TG, Coopersmith CM: Effects of aging on the immunopathologic response to sepsis. Crit Care Med 2009; 37:1018-23
37. Tetta C, Bellomo R, Inguaggiato P, Wratten ML, Ronco C: Endotoxin and cytokine removal in sepsis. Ther Apher 2002; 6:109-15
38. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24:1125-8
39. Ronco C, Ricci Z, Bellomo R: Importance of increased ultrafiltration volume and impact on mortality: Sepsis and cytokine story and the role for CVVH. Edtna Erca J 2002; Suppl 2:13-8
40. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d'Intini V, Bellomo R: Interpreting the mechanisms of continuous renal replacement therapy in sepsis: The peak concentration hypothesis. Artif Organs 2003; 27:792-801
41. Honore PM, Joannes-Boyau O: High volume hemofiltration (HVHF) in sepsis: A comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 2004; 27:1077-82
42. Honoré PM, Matson JR: Extracorporeal removal for sepsis: Acting at the tissue level-the beginning of a new era for this treatment modality in septic shock. Crit Care Med 2004; 32:896-7
43. Honoré PM, Joannes-Boyau O, Gressens B: Blood and plasma treatments: The rationale of high-volume hemofiltration. Contrib Nephrol 2007; 156:387-95
44. Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Béraud JJ: Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol 2002; 15:150-7
45. Di Carlo JV, Alexander SR: Hemofiltration for cytokinedriven illnesses: The mediator delivery hypothesis. Int J Artif Organs 2005; 28:777-86
46. Olszewski WL: The lymphatic system in body homeostasis: Physiological conditions. Lymphat Res Biol 2003; 1:11-24
47. Onarheim H, Missavage AE, Gunther RA, Kramer GC, Reed RK, Laurent TC: Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J Surg Res 1991; 50:259-65
48. Wasserman K, Mayerson HS: Dynamics of lymph and plasma protein exchange. Cardiologia 1952; 21:296-307
49. Peng Z, Singbartl K, Simon P, Rimmelé T, Bishop J, Clermont G, Kellum JA: Blood purification in sepsis: A new paradigm. Contrib Nephrol 2010; 165:322-8
50. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002; 30:1250-5
51. Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmüller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR: Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001; 29:1423-30
52. Call DR, Nemzek JA, Ebong SJ, Bolgos GL, Newcomb DE, Remick DG: Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment. Am J Pathol 2001; 158:715-21
53. Lerolle N, Nochy D, Guérot E, Bruneval P, Fagon JY, Diehl JL, Hill G: Histopathology of septic shock induced acute kidney injury: Apoptosis and leukocytic infiltration. Intensive Care Med 2010; 36:471-8
54. De Vriese AS, Vanholder RC, Pascual M, Lameire NH, Colardyn FA: Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intensive Care Med 1999; 25:903-10
55. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR: Diffusive versus convective therapy: Effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998; 26: 1995-2000
56. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C: A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30: 100-6
57. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E, Hemofiltration and Sepsis Group of the Collège National de Réanimation et de Médecine d'Urgence des Hôpitaux extra-Universitaires: Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit Care Med 2009; 37: 803-10
58. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P: High-volume haemofiltration in human septic shock. Intensive Care Med 2001; 27:978-86
59. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992; 18:235-40
60. Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB: High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 1994; 2:72-8
61. Wang H, Zhang ZH, Yan XW, Li WQ, Ji DX, Quan ZF, Gong DH, Li N, Li JS: Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis. World J Gastroenterol 2005; 11:127-31
62. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B: The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000; 161:1429-36
63. Rogiers P, Zhang H, Pauwels D, Vincent JL: Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock. Crit Care Med 2003; 31:1219-25
64. Grootendorst AF, van Bommel EF, van Leengoed LA, van Zanten AR, Huipen HJ, Groeneveld AB: Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993; 8:161-9
65. Lee PA, Matson JR, Pryor RW, Hinshaw LB: Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993; 21:914-24
66. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL: Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factoralpha attenuation during endotoxic shock. Crit Care Med 1999; 27:1848-55
67. Journois D, Israel-Biet D, Pouard P, Rolland B, Silvester W, Vouhé P, Safran D: High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. ANESTHESIOLOGY 1996; 85:965-76
68. Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhé P, Safran D: Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. ANESTHESIOLOGY 1994; 81:1181-9, 26A-27A
69. Cornejo R, Downey P, Castro R, Romero C, Regueira T, Vega J, Castillo L, Andresen M, Dougnac A, Bugedo G, Hernandez G: High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006; 32: 713-22
70. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28:3581-7
71. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G: Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. Asaio J 2004; 50:102-9
72. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF: Outcome of critically ill patients treated with intermittent high-volume haemofiltration: A prospective cohort analysis. Intensive Care Med 1999; 25:814-21
73. Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D'Intini V, Tetta C, Bellomo R, Ronco C: Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006; 32:80-6
74. Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, Ronco C: Pulse high-volume haemofiltration for treatment of severe sepsis: Effects on hemodynamics and survival. Crit Care 2005; 9:R294-302
75. Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, Spaulding C, Carli P, Dhainaut JF, Monchi M: High-volume hemofiltration after out-of-hospital cardiac arrest: A randomized study. J Am Coll Cardiol 2005; 46:432-7
76. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, Dhainaut JF, Cavaillon JM: Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 2002; 106:562-8
77. Jiang HL, Xue WJ, Li DQ, Yin AP, Xin X, Li CM, Gao JL: Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 2005; 11:4815-21
78. Bellomo R, Tetta C, Brendolan A, Ronco C: Coupled plasma filtration adsorption. Blood Purif 2002; 20:289-92
79. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C: Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial. JAMA 2009; 301:2445-52
80. Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH: Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006; 34:2099-104
81. Rimmelé T, Assadi A, Cattenoz M, Desebbe O, Lambert C, Boselli E, Goudable J, Etienne J, Chassard D, Bricca G, Allaouchiche B: High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant 2009; 24:421-7
82. Uchino S, Bellomo R, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P: Super high flux hemofiltration: A new technique for cytokine removal. Intensive Care Med 2002; 28:651-5
83. Mandolfo S, Galli F, Costa S, Ravani P, Gaggia P, Imbasciati E: Factors influencing permanent catheter performance. J Vasc Access 2001; 2:106-9
84. Ricci Z, Ronco C: Pre-versus post-dilution CVVH. Blood Purif 2005; 23:338
85. Bellomo R, Tan HK, Bhonagiri S, Gopal I, Seacombe J, Daskalakis M, Boyce N: High protein intake during continuous hemodiafiltration: Impact on amino acids and nitrogen balance. Int J Artif Organs 2002; 25:261-8
86. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE: Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000; 28:1161-5
87. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C, ESPEN: ESPEN guidelines on parenteral nutrition: Intensive care. Clin Nutr 2009; 28:387-400
88. Zhu Y, Zhang P, Yuan J, He Q, Jiang H, Hu X, Chen J: Adjunctive continuous high-volume hemofiltration in acute severe pancreatitis patients: A retrospective study. Scand J Gastroenterol 2009; 44:1363-9